157 related articles for article (PubMed ID: 38254201)
1. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy.
Takahashi J; Nagasawa S; Doi M; Takahashi M; Narita Y; Yamamoto J; Ikemoto MJ; Iwahashi H
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575921
[TBL] [Abstract][Full Text] [Related]
3. Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial.
Mikic N; Poulsen FR; Kristoffersen KB; Laursen RJ; Guldberg TL; Skjøth-Rasmussen J; Wong ET; Møller S; Dahlrot RH; Sørensen JCH; Korshøj AR
BMC Cancer; 2021 Sep; 21(1):1010. PubMed ID: 34503460
[TBL] [Abstract][Full Text] [Related]
4. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
[TBL] [Abstract][Full Text] [Related]
5. Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.
Stummer W; Müther M; Spille D
Acta Neurochir (Wien); 2024 Apr; 166(1):163. PubMed ID: 38563988
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
7. Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.
Vermandel M; Dupont C; Lecomte F; Leroy HA; Tuleasca C; Mordon S; Hadjipanayis CG; Reyns N
J Neurooncol; 2021 May; 152(3):501-514. PubMed ID: 33743128
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminolevulinic acid radiodynamic therapy for treatment of high-grade gliomas: A systematic review.
Nordmann NJ; Michael AP
Clin Neurol Neurosurg; 2021 Feb; 201():106430. PubMed ID: 33360951
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).
Thivat E; Casile M; Moreau J; Molnar I; Dufort S; Seddik K; Le Duc G; De Beaumont O; Loeffler M; Durando X; Biau J
BMC Cancer; 2023 Apr; 23(1):344. PubMed ID: 37060055
[TBL] [Abstract][Full Text] [Related]
10. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
11. Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial.
Hudson EM; Noutch S; Webster J; Brown SR; Boele FW; Al-Salihi O; Baines H; Bulbeck H; Currie S; Fernandez S; Hughes J; Lilley J; Smith A; Parbutt C; Slevin F; Short S; Sebag-Montefiore D; Murray L
BMJ Open; 2024 Mar; 14(3):e078926. PubMed ID: 38458809
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of
Yang DM; Cvetkovic D; Chen L; Ma CC
Biomed Phys Eng Express; 2022 Nov; 8(6):. PubMed ID: 36263662
[No Abstract] [Full Text] [Related]
13. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
14. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
Gainer JL; Sheehan JP; Larner JM; Jones DR
J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial.
Dupont C; Vermandel M; Leroy HA; Quidet M; Lecomte F; Delhem N; Mordon S; Reyns N
Neurosurgery; 2019 Jun; 84(6):E414-E419. PubMed ID: 30053213
[TBL] [Abstract][Full Text] [Related]
17. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
Geletneky K; Huesing J; Rommelaere J; Schlehofer JR; Leuchs B; Dahm M; Krebs O; von Knebel Doeberitz M; Huber B; Hajda J
BMC Cancer; 2012 Mar; 12():99. PubMed ID: 22436661
[TBL] [Abstract][Full Text] [Related]
18. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial.
Kong L; Gao J; Hu J; Lu R; Yang J; Qiu X; Hu W; Lu JJ
Cancer Commun (Lond); 2019 Feb; 39(1):5. PubMed ID: 30786916
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.
Diehl CD; Shiban E; Straube C; Gempt J; Wilkens JJ; Oechsner M; Kessel C; Zimmer C; Wiestler B; Meyer B; Combs SE
Cancer Commun (Lond); 2019 Nov; 39(1):73. PubMed ID: 31706337
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).
Arakawa Y; Sasaki K; Mineharu Y; Uto M; Mizowaki T; Mizusawa J; Sekino Y; Ono T; Aoyama H; Satomi K; Ichimura K; Kinoshita M; Ohno M; Ito Y; Nishikawa R; Fukuda H; Nishimura Y; Narita Y;
BMC Cancer; 2021 Oct; 21(1):1105. PubMed ID: 34654402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]